Moderna enters drug substance production deal with Lonza
Lonza Geleen plant will support the manufacturing of 300 million doses of Moderna’s booster Covid-19 variant vaccine yearly.
Netherlands
Latest in
Netherlands
AIM ImmunoTech initiates dosing in intranasal Covid-19 drug study
AIM ImmunoTech has dosed the first healthy participants in a Phase I clinical study of its Ampligen drug as a…
NewAmsterdam Pharma raises $196m through Series A funding round
Clinical stage company NewAmsterdam Pharma (NAP) has raised $196m (€160m) through Series A funding round to support the full Phase…
AM-Pharma enrols first Covid-19 patients in Phase III clinical trial
AM-Pharma has announced the enrolment of first participants in an exploratory cohort in Phase III REVIVAL pivotal trial of its…
KU Leuven, Batavia partner to develop Covid-19 vaccine candidate
KU Leuven in Belgium has partnered with contract development and manufacturing organisation, Batavia Biosciences, to develop a vector-based Covid-19 vaccine…
Lead Pharma enters oral molecules development deal with Roche
Lead Pharma has signed a collaboration and license agreement with Roche for the development of oral small molecules to treat…
Scenic Biotech forms drug development alliance with Genentech
Scenic Biotech has entered into a multi-year strategic partnership with Roche unit Genentech in a bid to discover, develop and…
Intravacc and Celonic team up to develop Covid-19 vaccine
Intravacc has partnered with contract development and manufacturing organisation (CDMO) Celonic Group for the design, development and production of a…